ERBB2 and breast cancer: This point acquires even more relevance, since it has been shown that HER2 status determination through the same protocol used for breast cancer, might lead to significant loss of patients [66] as there are important and significant differences in HER2 status determination between the two types of cancer (Table 2, see also [67]).